# A Phase II Trial of rsCD4 and AZT in Patients With AIDS or Advanced AIDS Related Complex (ARC)

> **NCT00000659** · PHASE2 · TERMINATED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 80 (—)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** CD4 Antigens
- **DRUG:** Zidovudine

## Key facts

- **NCT ID:** NCT00000659
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** —
- **Primary completion:** 1990-07
- **Final completion:** —
- **Target enrollment:** 80 (—)
- **Last updated:** 2011-03-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00000659

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00000659, "A Phase II Trial of rsCD4 and AZT in Patients With AIDS or Advanced AIDS Related Complex (ARC)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00000659. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*